- Companies
- Hipromine
Hipromine Valuation Multiples
Hipromine is valued at $16M as of September 2026, a 19.2x revenue multiple. In the last fiscal year, Hipromine revenue was $3M and Hipromine EBITDA was ($5M).
Hipromine Overview
About Hipromine
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company’s offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
Founded
2015
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$60M
Valuation Multiples
Start free trialHipromine Financials
Hipromine reported last fiscal year revenue of $3M and negative EBITDA of ($5M).
In the same fiscal year, Hipromine generated $249K in gross profit, ($5M) in EBITDA losses, and had net loss of ($12M).
Hipromine P&L
In the most recent fiscal year, Hipromine reported revenue of $3M and EBITDA of ($5M).
Hipromine is unprofitable as of last fiscal year, with gross margin of 8%, EBITDA margin of (171%), and net margin of (391%).
Financial data powered by Morningstar, Inc.
Hipromine Stock Performance
Hipromine has current market cap of $16M, and enterprise value of $60M.
Market Cap Evolution
Hipromine's stock price is $12.06.
Hipromine share price decreased by 32.4% in the last 30 days, and by 55.3% in the last year.
Hipromine has an EPS (earnings per share) of $-9.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $60M | $16M | 0.1% | -32.4% | -47.2% | -55.3% | $-9.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHipromine Valuation Multiples
Hipromine trades at 19.2x EV/Revenue multiple, and (11.2x) EV/EBITDA.
Hipromine Financial Valuation Multiples
As of September 22, 2026, Hipromine has market cap of $16M and EV of $60M.
Hipromine has a P/E ratio of (1.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hipromine Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hipromine Margins & Growth Rates
In the most recent fiscal year, Hipromine reported gross margin of 8%, EBITDA margin of (171%), and net margin of (391%).
Hipromine Margins
Hipromine Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hipromine Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Hipromine Competitors
Hipromine competitors include Epsium Enterprise, Vitaminka, Golda Gida, Merko Gıda, Precision Peptide Co, Barfresh Food Group, Bio Planet, KKO International, Slaturfelag Suourlands and Industrias Productos Alimenticios.
Most Hipromine public comparables operate across Food & Beverages.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $5M | ($1M) | 2.9x | - | (10.1x) | - | |||
| $66M | $6M | 0.3x | - | 2.9x | - | |||
| $53M | $578K | 0.1x | - | 11.6x | - | |||
| $13M | $8M | 1.8x | - | 2.9x | - | |||
| $36K | ($3M) | 392.9x | - | (4.4x) | - | |||
| $14M | ($2M) | 1.8x | 1.3x | (10.8x) | (11.2x) | |||
| $82M | $3M | 0.2x | - | 5.4x | - | |||
| $20M | $3M | 1.1x | - | 7.3x | - | |||
This data is available for Pro users. Sign up to see all Hipromine competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hipromine
| When was Hipromine founded? | Hipromine was founded in 2015. |
| Where is Hipromine headquartered? | Hipromine is headquartered in Poland. |
| Is Hipromine publicly listed? | Yes, Hipromine is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Hipromine? | Hipromine trades under HPM ticker. |
| When did Hipromine go public? | Hipromine went public in 2022. |
| Who are competitors of Hipromine? | Hipromine main competitors include Epsium Enterprise, Vitaminka, Golda Gida, Merko Gıda, Precision Peptide Co, Barfresh Food Group, Bio Planet, KKO International, Slaturfelag Suourlands, Industrias Productos Alimenticios. |
| What is the current market cap of Hipromine? | Hipromine's current market cap is $16M. |
| What is the current revenue of Hipromine? | Hipromine's last fiscal year revenue is $3M. |
| What is the current EV/Revenue multiple of Hipromine? | Current revenue multiple of Hipromine is 19.2x. |
| Is Hipromine profitable? | No, Hipromine is not profitable. |
| How many companies Hipromine has acquired to date? | Hipromine hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hipromine has invested to date? | Hipromine hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Hipromine
Lists including Hipromine
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




